Arcturus Therapeutics (ARCT) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mailGet Alerts ARCT Hot Sheet
Price: $16.74 --0%
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Join SI Premium – FREE
Wells Fargo analyst Yanan Zhu lowered the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $20.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $370 at Rosenblatt
- Snowflake Inc. (SNOW) PT Raised to $425 at Mizuho
- Citi raises Broadcom price target to $515 amid AI outlook
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
